Abstract:Background: Soft markers are common prenatal ultrasonographic findings that indicate an increased risk for fetal aneuploidy. However, the association between soft markers and pathogenic or likely pathogenic copy number variations is still unclear, and clinicians lack clarity on which soft markers warrant a recommendation for invasive prenatal genetic testing of the fetus. Objective: This study aimed to provide guidance on ordering prenatal genetic testing for fetuses with different soft markers and to elucidate the association between specific types of chromosomal abnormalities and specific ultrasonographic soft markers. Study design: Low-pass genome sequencing was performed for 15,263 fetuses, including 9123 with ultrasonographic soft markers and 6140 with normal ultrasonographic findings. The detection rate of pathogenic or likely pathogenic copy number variants among fetuses with various ultrasonographic soft markers were compared with that of fetuses with normal ultrasonography. The association of soft markers with aneuploidy and pathogenic or likely pathogenic copy number variants were investigated using Fisher exact tests with Bonferroni correction. Results: The detection rate of aneuploidy and pathogenic or likely pathogenic copy number variants was 3.04% (277/9123) and 3.40% (310/9123), respectively, in fetuses with ultrasonographic soft markers. An absent or a hypoplastic nasal bone was the soft marker in the second trimester with the highest diagnostic rate for aneuploidy of 5.22% (83/1591) among all isolated groups. Four types of isolated ultrasonographic soft markers, namely a thickened nuchal fold, single umbilical artery, mild ventriculomegaly, and absent or hypoplastic nasal bone, had higher diagnostic rates for pathogenic or likely pathogenic copy number variants (P<.05; odds ratio, 1.69-3.31). Furthermore, this study found that the 22q11.2 deletion was associated with an aberrant right subclavian artery, whereas the 16p13.11 deletion, 10q26.13-q26.3 deletion, and 8p23.3-p23.1 deletion were associated with a thickened nuchal fold, and the 16p11.2 deletion and 17p11.2 deletion were associated with mild ventriculomegaly (P<.05). Conclusion: Ultrasonographic phenotype-based genetic testing should be considered in clinical consultations. Copy number variant analysis is recommended for fetuses with an isolated thickened nuchal fold, a single umbilical artery, mild ventriculomegaly, and an absent or a hypoplastic nasal bone. A comprehensive definition of genotype-phenotype correlations in aneuploidy and pathogenic or likely pathogenic copy number variants could provide better information for genetic counseling.

Chromosomal Microarray Analysis in Fetuses With Ultrasonographic Soft Markers: A Meta-Anaysis of the Current Evidence

Chromosomal Microarray Analysis in Fetuses with Congenital Anomalies of the Kidney and Urinary Tract: A Prospective Cohort Study and Meta‐analysis

Evaluation of chromosomal abnormalities and copy number variations in fetuses with ultrasonic soft markers

Clinical Application Of Chromosomal Microarray Analysis In Pregnant Women With Advanced Maternal Age And Fetuses With Ultrasonographic Soft Markers

Should chromosomal microarray be offered to fetuses with ultrasonographic soft markers in second trimester: A prospective cohort study and meta-analysis

Chromosomal Microarray Analysis in Fetuses with Ultrasound Abnormalities

Comparison of Chromosomal Microarray Analysis and Noninvasive Prenatal Testing in Pregnant Women with Fetal Ultrasonic Soft Markers

Clinical Experience of Prenatal Chromosomal Microarray Analysis in 6159 Ultrasonically Abnormal Fetuses

Association analysis between chromosomal abnormalities and fetal ultrasonographic soft markers based on 15,263 fetuses

Chromosomal Microarray Analysis in Fetuses with High-Risk Prenatal Indications: A Retrospective Study in China.

Clinical Application of Chromosomal Microarray Analysis for Fetuses with Craniofacial Malformations

Clinical Analysis Of 194 Cases Of Amniotic Fluid Chromosome Microarray Detection

Application of chromosome microarray analysis in prenatal diagnosis

The Application of Chromosomal Microarray Analysis to the Prenatal Diagnosis of Isolated Mild Ventriculomegaly

A Three-Year Prospective Study Assessing the Application of Chromosomal Microarray Analysis in 576 High-Risk Pregnant Women

Clinical Application of Chromosomal Microarray Analysis in Fetuses with Congenital Heart Disease

Abnormal Chromosomes Identification Using Chromosomal Microarray

Prenatal Diagnosis Using Chromosomal Microarray Analysis in High-Risk Pregnancies

Clinical Application Of Chromosomal Microarray Analysis For The Prenatal Diagnosis Of Chromosomal Abnormalities And Copy Number Variations In Fetuses With Congenital Heart Disease (Vol 38, Pg 406, 2018)

Detection of copy number variants using chromosomal microarray analysis for the prenatal diagnosis of congenital heart defects with normal karyotype.

The likelihood of detecting abnormal karyotypes in fetuses with a single major anomaly or “soft” marker on ultrasonographic scanning